MedPath

OMVOH

OMVOH

Approved
DIN Number

02539861

Drug Class

Human

Market Date

Oct 3, 2023

Company
HC

eli lilly canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02539861
AIG Number0164841002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L04AC24 MIRIKIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification56:44.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

MIRIKIZUMABActive
Strength: 20 MG / ML
Monograph: MIRIKIZUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.